Connect Biopharma Holdings Ltd

Report topline data from Phase 2 Seabreeze STAT COPD study

Deadline passed; outcome being checked

Announced: 15 Sep 2026
Due: 30 Sep 2026
Status: Checking

Deadline
Met
Late
Not met
Today

What the company said

“Connect expects to report topline data from the ongoing Phase 2 Seabreeze STAT COPD study later this month”

SourceConnect Biopharma Holdings Ltd Form 8-K press release, 2026-09-15
FilingSEC filing index
Deadline as statedlater this month
Deadline used30 Sep 2026, the last day of the stated period
TypeProject
Permanent referenceKI-C-2026-CNTB-000731
Cite as https://keptindex.org/c/KI-C-2026-CNTB-000731/ — this address never changes.

What we found

The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Clinical readout
Indicative materiality: Medium rules
Action: Report
Language: Expected (“expects”, “plans”)

Tell me what happens

This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.

Alert me when this resolves

How this entry was checked

Commitment recordedRecorded from the company's filing.
OutcomeNot yet assessed. Nothing is judged before the deadline.

Are you Connect Biopharma Holdings Ltd? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2026-CNTB-000731 · Corrections policy